Theralink Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch THER and buy or sell other stocks, ETFs, and their options commission-free!

About THER

Theralink Technologies, Inc. is a precision medicine company, which engages in the development of novel cancer immunotherapy products. It offers the reverse phase protein array technology platform that can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. 

CEO
Faith Zaslavsky
CEOFaith Zaslavsky
Employees
16
Employees16
Headquarters
Golden, Colorado
HeadquartersGolden, Colorado
Founded
2005
Founded2005
Employees
16
Employees16

THER Key Statistics

Market cap
615.15K
Market cap615.15K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
191.53K
Average volume191.53K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.001
52 Week high$0.001
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

With a market cap of 615.15K, Theralink Technologies(THER) trades at $0.00.

On 2026-06-07, Theralink Technologies(THER) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Theralink Technologies(THER) stock has reached 0, versus its average volume of 191.53K.

The stock's 52-week range extends from a low of $0.00 to a high of $0.00.

The stock's 52-week range extends from a low of $0.00 to a high of $0.00.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.